NO20026148D0 - Medisiner for forhindring og behandling av neurodegenerative sykdommer - Google Patents
Medisiner for forhindring og behandling av neurodegenerative sykdommerInfo
- Publication number
- NO20026148D0 NO20026148D0 NO20026148A NO20026148A NO20026148D0 NO 20026148 D0 NO20026148 D0 NO 20026148D0 NO 20026148 A NO20026148 A NO 20026148A NO 20026148 A NO20026148 A NO 20026148A NO 20026148 D0 NO20026148 D0 NO 20026148D0
- Authority
- NO
- Norway
- Prior art keywords
- medicines
- prevention
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000185814 | 2000-06-21 | ||
| PCT/JP2001/004934 WO2001098300A1 (fr) | 2000-06-21 | 2001-06-12 | Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20026148D0 true NO20026148D0 (no) | 2002-12-20 |
| NO20026148L NO20026148L (no) | 2003-02-20 |
Family
ID=18686074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20026148A NO20026148L (no) | 2000-06-21 | 2002-12-20 | Medisiner for forhindring og behandling av neurodegenerative sykdommer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6743803B2 (no) |
| EP (1) | EP1295883A4 (no) |
| KR (1) | KR20030010740A (no) |
| CN (1) | CN100354274C (no) |
| AU (2) | AU2001262741B2 (no) |
| BR (1) | BR0111799A (no) |
| CA (1) | CA2412199A1 (no) |
| CZ (1) | CZ20024153A3 (no) |
| EE (1) | EE04941B1 (no) |
| HU (1) | HUP0301319A3 (no) |
| IL (2) | IL153439A0 (no) |
| MX (1) | MXPA02012599A (no) |
| NO (1) | NO20026148L (no) |
| NZ (1) | NZ523189A (no) |
| PL (1) | PL200537B1 (no) |
| RU (1) | RU2258506C2 (no) |
| SK (1) | SK17682002A3 (no) |
| TW (1) | TWI298068B (no) |
| WO (1) | WO2001098300A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822097B1 (en) * | 2002-02-07 | 2004-11-23 | Amgen, Inc. | Compounds and methods of uses |
| TW200533371A (en) * | 2004-04-15 | 2005-10-16 | Dainippon Pharmaceutical Co | Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
| EP1595881A1 (en) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands |
| WO2010002451A1 (en) * | 2008-07-01 | 2010-01-07 | Concert Pharmaceuticals, Inc. | Naphthyridin derivatives |
| JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
| BR112022000811A2 (pt) * | 2019-07-18 | 2022-03-29 | Abaxys Therapeutics | Formulação sólida de um derivado de 1,2,4-oxadiazol |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2683818B1 (fr) * | 1991-11-14 | 1993-12-31 | Adir Cie | Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JPH09291034A (ja) * | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
| ZA985870B (en) * | 1997-07-15 | 1999-01-27 | Dainippon Pharmaceutical Co | 5-substituted-3-oxadiazolyl-1, 6-naphthyridin-2(1H)-one derivatives |
| AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
| WO2000073283A1 (en) * | 1999-06-02 | 2000-12-07 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
-
2001
- 2001-06-06 TW TW090113656A patent/TWI298068B/zh not_active IP Right Cessation
- 2001-06-12 BR BR0111799-8A patent/BR0111799A/pt not_active Application Discontinuation
- 2001-06-12 US US10/311,932 patent/US6743803B2/en not_active Expired - Fee Related
- 2001-06-12 AU AU2001262741A patent/AU2001262741B2/en not_active Ceased
- 2001-06-12 NZ NZ523189A patent/NZ523189A/en unknown
- 2001-06-12 IL IL15343901A patent/IL153439A0/xx active IP Right Grant
- 2001-06-12 HU HU0301319A patent/HUP0301319A3/hu unknown
- 2001-06-12 CA CA002412199A patent/CA2412199A1/en not_active Abandoned
- 2001-06-12 EE EEP200200698A patent/EE04941B1/xx not_active IP Right Cessation
- 2001-06-12 KR KR1020027017221A patent/KR20030010740A/ko not_active Application Discontinuation
- 2001-06-12 EP EP01936958A patent/EP1295883A4/en not_active Withdrawn
- 2001-06-12 AU AU6274101A patent/AU6274101A/xx active Pending
- 2001-06-12 RU RU2003101405/04A patent/RU2258506C2/ru not_active IP Right Cessation
- 2001-06-12 WO PCT/JP2001/004934 patent/WO2001098300A1/ja active IP Right Grant
- 2001-06-12 SK SK1768-2002A patent/SK17682002A3/sk unknown
- 2001-06-12 MX MXPA02012599A patent/MXPA02012599A/es active IP Right Grant
- 2001-06-12 CN CNB018142834A patent/CN100354274C/zh not_active Expired - Fee Related
- 2001-06-12 CZ CZ20024153A patent/CZ20024153A3/cs unknown
- 2001-06-12 PL PL363869A patent/PL200537B1/pl not_active IP Right Cessation
-
2002
- 2002-12-15 IL IL153439A patent/IL153439A/en not_active IP Right Cessation
- 2002-12-20 NO NO20026148A patent/NO20026148L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI298068B (en) | 2008-06-21 |
| BR0111799A (pt) | 2003-05-27 |
| EP1295883A1 (en) | 2003-03-26 |
| CN1447809A (zh) | 2003-10-08 |
| NO20026148L (no) | 2003-02-20 |
| US6743803B2 (en) | 2004-06-01 |
| MXPA02012599A (es) | 2003-05-14 |
| CN100354274C (zh) | 2007-12-12 |
| EE04941B1 (et) | 2007-12-17 |
| HUP0301319A2 (hu) | 2003-09-29 |
| KR20030010740A (ko) | 2003-02-05 |
| SK17682002A3 (sk) | 2003-08-05 |
| AU6274101A (en) | 2002-01-02 |
| WO2001098300A1 (fr) | 2001-12-27 |
| CZ20024153A3 (cs) | 2003-06-18 |
| EP1295883A4 (en) | 2003-06-11 |
| CA2412199A1 (en) | 2001-12-27 |
| NZ523189A (en) | 2004-08-27 |
| RU2258506C2 (ru) | 2005-08-20 |
| IL153439A0 (en) | 2003-07-06 |
| PL363869A1 (en) | 2004-11-29 |
| US20030166673A1 (en) | 2003-09-04 |
| PL200537B1 (pl) | 2009-01-30 |
| IL153439A (en) | 2007-07-24 |
| HUP0301319A3 (en) | 2008-06-30 |
| AU2001262741B2 (en) | 2005-07-07 |
| EE200200698A (et) | 2004-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015773D0 (no) | Forhindring og behandling av amyloidogen sykdom | |
| NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
| NO20014046D0 (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
| ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
| EP1399171A4 (en) | MEDICINAL HERB COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DIABETES | |
| IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
| NO994014L (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
| PT1083889E (pt) | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas | |
| PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| NO20014617D0 (no) | 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| NO20023448L (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
| ATE431142T1 (de) | Arzneimittel zur behandlung und vermeidung neurogener schmerzen | |
| NO20024777D0 (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
| AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| NO20026148D0 (no) | Medisiner for forhindring og behandling av neurodegenerative sykdommer | |
| NO20020784L (no) | Medikament for behandling av brudd | |
| NO20020369L (no) | Sammensetninger for forebyggelse og behandling av nyredysfunksjoner og -sykdommer | |
| IS6707A (is) | Efnablanda til forvarna og meðhöndlunar á krabbameini | |
| AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| NO20013651D0 (no) | Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |